This topic contains a solution. Click here to go to the answer

Author Question: When monitoring a patient who is taking a systemically administered glucocorticoid, the nurse will ... (Read 38 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
When monitoring a patient who is taking a systemically administered glucocorticoid, the nurse will monitor for signs of which condition?
 
  a. Dehydration
  b. Hypokalemia
  c. Hyponatremia
  d. Hypoglycemia

Question 2

A glucocorticoid is prescribed for a patient.
 
  The nurse checks the patient's medical history knowing that glucocorticoid therapy is contraindicated in which disorder?
  a. Cerebral edema
  b. Peptic ulcer disease
  c. Tuberculous meningitis
  d. Chronic obstructive pulmonary disease



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

stano32

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: B

Answer to Question 2

ANS: B




lilldybug07

  • Member
  • Posts: 546
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library